Novatreat Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Novatreat General Information

Description

Developer of products for the prevention and therapy of infectious diseases. The company develops immunoglobulin concentrate products from milk for preventing infectious diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Helsinki Science Park
  • Viikinkaari 6
  • 00710 Helsinki
  • Finland
Primary Industry
Biotechnology
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Helsinki Science Park
  • Viikinkaari 6
  • 00710 Helsinki
  • Finland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novatreat Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 30-Jun-2004 Completed Generating Revenue
3. Secondary Transaction - Private 01-Sep-2003 Completed Generating Revenue
2. Early Stage VC 03-Jul-2000 Completed Startup
1. Early Stage VC 30-Jun-1998 Completed Startup
To view Novatreat’s complete valuation and funding history, request access »

Novatreat Patents

  • 20

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Novatreat Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025133541-A1 Device for preparing a gaseous premix, flame treatment unit and method using said device Inactive 21-Dec-2023
FR-3157226-A1 Device for preparing a gaseous premixture, flaming unit and method using this device Pending 21-Dec-2023
ES-2234552-T3 A method for calostro treatment. Inactive 25-May-1999
CA-2309226-A1 A method of treating colostrum Inactive 25-May-1999
EP-1055372-A2 A method of treating colostrum Active 25-May-1999 A23C9/206
To view Novatreat’s complete patent history, request access »

Novatreat Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aboa Venture Management PE/Buyout Minority
BioFund Ventures Venture Capital Minority
To view Novatreat’s complete investors history, request access »

Ready to get started?

Request a free trial

Novatreat FAQs

  • When was Novatreat founded?

    Novatreat was founded in 1997.

  • Where is Novatreat headquartered?

    Novatreat is headquartered in Helsinki, Finland.

  • What industry is Novatreat in?

    Novatreat’s primary industry is Biotechnology.

  • Is Novatreat a private or public company?

    Novatreat is a Private company.

  • What is Novatreat’s current revenue?

    The current revenue for Novatreat is .

  • Who are Novatreat’s investors?

    Aboa Venture Management and BioFund Ventures have invested in Novatreat.

  • When was Novatreat acquired?

    Novatreat was acquired on 30-Jun-2004.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process